Tech Company Financing Transactions

GenomeDx Biosciences Funding Round

GenomeDx Biosciences closed a Series A funding round on 1/10/2012. Investors included Aeris Capital AG, Baird Capital and private investors.

Transaction Overview

Announced On
1/10/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors

Aeris Capital AG (Lead Investor) (George Rehm)

Baird Capital (Lead Investor) (Michael Liang)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1152 Mainland St. 430
Vancouver BC, V6B 4X2
Canada
Email Address
Overview
GenomeDx is a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers.
Profile
GenomeDx Biosciences LinkedIn Company Profile
Social Media
GenomeDx Biosciences Company Twitter Account
Company News
GenomeDx Biosciences News
Facebook
GenomeDx Biosciences on Facebook
YouTube
GenomeDx Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Medical Officer
Douglas Dolginow
  Douglas Dolginow LinkedIn Profile  Douglas Dolginow Twitter Account  Douglas Dolginow News  Douglas Dolginow on Facebook
President
Elai Davicioni
  Elai Davicioni LinkedIn Profile  Elai Davicioni Twitter Account  Elai Davicioni News  Elai Davicioni on Facebook
VP - General Counsel
Adam Chinnock
  Adam Chinnock LinkedIn Profile  Adam Chinnock Twitter Account  Adam Chinnock News  Adam Chinnock on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/10/2012: VideoIQ venture capital transaction
Next: 1/10/2012: EveryMove venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site come from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary